Opinion
Video
Author(s):
A panelist discusses how targeted gene therapy, particularly nadofaragene firadenovec, represents a paradigm shift in BCG-unresponsive NMIBC treatment.
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.